Loading
Obesity · Journal article
Adipocyte · August 20, 2026
A consensus or society position rather than new primary data.
This narrative review synthesizes evidence on the biological and clinical interactions between lipedema and obesity, disorders that frequently coexist and may aggravate one another. The authors propose that lipedema and obesity should be assessed as potentially coexisting and mutually modifying conditions rather than mutually exclusive diagnoses, and derive implications for staged, individualized management. The framework is explicitly intended to support clinical reasoning and research prioritization, not to serve as a formal guideline or replace formal diagnostic protocols.
Narrative review. Adult women with suspected or confirmed lipedema, including those with coexisting overweight or obesity.
Lipedema and obesity present with overlapping phenotypes: increased adipose-tissue volume, body circumference, functional impairment, and psychological burden Obesity is increasingly conceptualized as an adiposity-based chronic disease characterized by excess adipose tissue, abnormal distribution or dysfunction, and associated medical or functional impairment, rather than solely by BMI ≥ 30 kg/m² Obesity can impair lymphatic morphology and function, whereas lymphatic dysfunction may promote subcutaneous adipose-tissue expansion and fibrosis
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should recognize lipedema and obesity as frequently coexisting, mutually modifying conditions rather than differential diagnoses, and adopt staged, interdisciplinary approaches that address both adipose-tissue dysfunction and lymphatic impairment. The proposed framework supports individualized reasoning about diagnosis and management, including conservation, pharmacology, bariatric surgery, and liposuction, but does not replace formal guidelines.
A narrative review synthesizing clinical and biological evidence on lipedema and obesity interaction, intended to support clinical reasoning and interdisciplinary management rather than to estimate treatment effects or replace formal guidelines.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians should recognize lipedema and obesity as frequently coexisting, mutually modifying conditions rather than differential diagnoses, and adopt staged, interdisciplinary approaches that address both adipose-tissue dysfunction and lymphatic impairment. The proposed framework supports individualized reasoning about diagnosis and management, including conservation, pharmacology, bariatric surgery, and liposuction, but does not replace formal guidelines.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Lipedema and obesity are chronic, frequently progressive disorders that can present with increased adipose-tissue volume, functional impairment and reduced quality of life. Although often approached as differential diagnoses, they frequently coexist and may aggravate one another. This narrative review addresses how lipedema and obesity interact biologically and clinically and what evidence supports a staged interdisciplinary approach to diagnosis and management. Obesity is increasingly conceptualized as an adiposity-based chronic disease characterized by excess adipose, abnormal adipose-tissue distribution or dysfunction, and associated medical or functional impairment. Obesity can impair lymphatic morphology and function, whereas lymphatic dysfunction may promote subcutaneous adipose-tissue expansion and fibrosis. Literature was identified through iterative PubMed searches and focused supplementary searches in Embase and the Cochrane Library. Publications were selected purposively for their relevance to predefined clinical and mechanistic domains; no systematic screening or formal risk-of-bias assessment was performed. This review synthesizes clinical overlap, biological evidence, diagnostic implications, and staged management for predominantly adult women with suspected or confirmed lipedema, including those with coexisting overweight or obesity. The proposed framework is intended to support clinical reasoning rather than serve as a formal guideline.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.